EP3534899
EFNASAMBÖND OG AÐFERÐIR VIÐ AÐ MÓTA T-FRUMUKÍNASA SEM ER VIRKJANLEGUR MEÐ INTERLEUKIN-2
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.11.2017EP published:
1.6.2022EP application number:
17868729.9
EP translation filed:
15.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
2.11.2037Expiry date:
2.11.2026Next due date:
30.11.2026
Title in English:
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASELanguage of the patent:
English
Timeline
Today
3.11.2017EP application
1.6.2022EP Publication
15.6.2022Translation submitted
15.7.2022Registration published
2.11.2026Expires
Owner
Name:
Corvus Pharmaceuticals, Inc.Address:
863 Mitten Road Suite 102, Burlingame, CA 94010, US
Inventor
Name:
HUDSON, RyanAddress:
Burlingame, CA 94010, US
Name:
BEAUSOLEIL, Anne-MarieAddress:
Burlingame, CA 94010, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662417083 PDate:
3.11.2016Country:
US
Classification
Categories:
C07D 277/54, C07D 417/12, C07D 487/10, A61K 31/426, A61K 31/427, A61K 31/428, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 29.12.2022
Expires: 2.11.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 15.11.2023
Expires: 2.11.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.11.2024
Expires: 2.11.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.11.2025
Expires: 2.11.2026
Payer: Árnason Faktor ehf.